GUILFORD, Conn.–(BUSINESS WIRE)–Feb. 17, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the 43rd Annual Cowen Health Care Conference taking place at the Boston Marriott Copley Place, Boston, MA on March 6-8, 2023. Quantum-Si’s management will present on Tuesday, March 7, […]
GUILFORD, Conn.–(BUSINESS WIRE)–Feb. 13, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results for the fourth quarter and full year 2022 before market open on Monday, March 6, 2023. Company management will host a conference call to discuss financial results and provide […]
Protein Enrichment Kits to Enable Deep Interrogation of Proteoforms through Protein Sequencing GUILFORD, Conn.–(BUSINESS WIRE)–Jan. 9, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it entered into a partnership with Aviva Systems Biology, a leading provider of antibody, protein, and immunoassay reagent products with an extensive […]
Partnership Joins Protein Sequencing Technology With AI Visualization to Further Unlock the Human Proteome for Novel Drug Discovery Key Takeaways This partnership combines Quantum-Si’s expertise in single molecule protein sequencing with Biovista’s AI visualization technology to facilitate faster and more efficient protein drug target discovery. GUILFORD, Conn.–(BUSINESS WIRE)–Jan. 9, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” […]
Company Announces Commercial Shipments of Protein Sequencing System, Reveals New Partnerships, and Reaffirms Commitment to Financial Discipline Launched in December 2022, Platinum is the First Commercially Available Next-Generation Single-Molecule Protein Sequencing System Looking to Unlock the Proteome One Amino Acid at a Time GUILFORD, Conn.–(BUSINESS WIRE)–Jan. 9, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or […]
GUILFORD, Conn.–(BUSINESS WIRE)– Dec. 22, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference taking place at the Westin St. Francis, San Francisco, CA on January 9-12, 2023. Quantum-Si’s management will present on Thursday, January 12 […]
Quantum-Si combines Time Domain Sequencing™ and Semiconductor Chip Technology to Advance Drug Discovery and Diagnostics and Accelerate Scientific Breakthroughs, Helping People to Live Healthier and Longer Lives Company Appoints Life Science Veteran Grace Johnston, PhD, as Chief Commercial Officer Key Takeaways: The accessibility gained when using Platinum™ is expected to transform science and understanding of the […]
GUILFORD, Conn.–(BUSINESS WIRE)– Nov. 07, 2022 — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing the first next-generation, single-molecule protein sequencing platform, today announced financial results for the third quarter ending September 30, 2022. Recent Highlights Appointed Jeff Hawkins as Chief Executive Officer and director to the Board. Announced […]
GUILFORD, Conn.–(BUSINESS WIRE)– Nov. 03, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing the first-next generation single-molecule protein sequencing platform, today announced that it will be participating in the 16th Annual Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum taking place at the Westin New York Grand Central, […]
GUILFORD, Conn.–(BUSINESS WIRE)– Oct. 17, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing the first next-generation single-molecule protein sequencing platform, today announced that it will report financial results for the third quarter 2022 after market close on Monday, November 7, 2022. Company management will host a conference call to discuss […]